We are live on ! Find out more
MXCT icon

MaxCyte

120 hedge funds and large institutions have $156M invested in MaxCyte in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

22% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 36

4% more funds holding

Funds holding: 115120 (+5)

4.59% less ownership

Funds ownership: 71.66%67.06% (-4.6%)

25% less capital invested

Capital invested by funds: $208M → $156M (-$51.9M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
120
Holders Change
+5
Holders Change %
+4.35%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
21
Increased
44
Reduced
36
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$151K -$26.2K -10,831 -14%
Deutsche Bank
52
Deutsche Bank
Germany
$151K -$44K -18,167 -21%
Wells Fargo
53
Wells Fargo
California
$141K +$3.34K +1,379 +2%
Los Angeles Capital Management
54
Los Angeles Capital Management
California
$138K +$153K +63,330 New
ECP
55
Epacria Capital Partners
Colorado
$135K +$96.4K +39,796 +178%
IIM
56
INTECH Investment Management
Florida
$134K +$2.34K +965 +2%
EC
57
EntryPoint Capital
New York
$134K -$165K -67,939 -53%
MIM
58
MetLife Investment Management
New Jersey
$131K +$22 +9 +0%
Mirae Asset Global ETFs Holdings
59
Mirae Asset Global ETFs Holdings
Hong Kong
$121K -$17.5K -7,242 -12%
Jane Street
60
Jane Street
New York
$116K -$25.6K -10,576 -17%
T. Rowe Price Associates
61
T. Rowe Price Associates
Maryland
$113K +$15.5K +6,388 +14%
Invesco
62
Invesco
Georgia
$110K +$9.15K +3,780 +8%
SA
63
Sanctuary Advisors
Indiana
$109K +$121K +50,116 New
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$83.3K -$2.72K -1,123 -3%
HF
65
HRT Financial
New York
$81K +$49.9K +20,595 +122%
VOYA Investment Management
66
VOYA Investment Management
Georgia
$68.4K +$1.67K +689 +2%
QC
67
Quadrature Capital
United Kingdom
$60.4K +$67.2K +27,760 New
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$56.7K +$45.8K +18,913 +267%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$54.7K
ProShare Advisors
70
ProShare Advisors
Maryland
$53.9K -$7.17K -2,961 -11%
SG Americas Securities
71
SG Americas Securities
New York
$52K -$27.2K -11,248 -32%
Squarepoint
72
Squarepoint
New York
$50.1K -$95.9K -39,605 -63%
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$47.6K
D.E. Shaw & Co
74
D.E. Shaw & Co
New York
$47K -$146K -60,212 -74%
CUAMC
75
China Universal Asset Management Company
China
$46.6K +$475 +196 +0.9%

MXCT Hedge Fund Activity: Q2 2025 in Review

120 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2025, worth a combined $156M — down 25% from $208M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new MXCT positions and 16 closed out — a net gain of 5 holders — while 44 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $4.92M. The largest seller was Swedbank, exiting entirely with an estimated $3.79M sold.

  • 120 institutional investors held MaxCyte (MXCT) as of Q2 2025, up from 115 in Q1 2025.
  • Funds reported $156M of MaxCyte stock for Q2 2025, down 25% quarter-over-quarter.
  • 21 funds opened new MaxCyte positions in Q2 2025 and 16 closed out, a net change of +5 holders.
  • The largest MaxCyte buyer in Q2 2025 was BlackRock, an estimated $4.92M added.
  • The largest MaxCyte seller in Q2 2025 was Swedbank, an estimated $3.79M sold.

Based on aggregated 13F filings for Q2 2025.